Recent Updates
Recently added Catalysts
BVS Positive Sentiment Score: 70/100

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

Thursday, March 16, 2023 2 min read
Key Takeaway: Bioventus Inc. has announced that it will report financial results for the fourth quarter of fiscal year 2022 on March 30, 2023. A conference call with management will take place at 8:30 a.m. Eastern Time to discuss these results and provide a business update. Interested parties can participate via phone or through a live webcast, which will also be archived for later access. The company emphasizes its mission to support active healing and patient recovery.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bioventus is set to report its fourth-quarter financial results, indicating ongoing transparency with investors.
  • The company's commitment to high-quality standards and ethics supports its reputation in the market.
  • The upcoming conference call provides an opportunity for stakeholders to gain insights into the company's performance.

Full Press Release Details

DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before the market opens on Thursday, March 30, 2023. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 29, 2024.
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave.Crawford@bioventus.com

Frequently Asked Questions

When will Bioventus report its Q4 2022 financial results?

Bioventus will report its Q4 2022 results on March 30, 2023.

What time is the conference call for Q4 2022 results?

The conference call is scheduled for 8:30 a.m. Eastern Time.

How can I access the Bioventus conference call?

Dial 1-833-636-0497 for domestic or +1-412-902-4241 for international access.

Where can I find the webcast of the conference call?

The webcast will be available on the Investor Relations section of Bioventus' website.

What is Bioventus known for?

Bioventus specializes in innovations for active healing and cost-effective products.

Tags: BVS Viatris Investor Conferences Healthcare Bioventus Q4 2022 financial results conference call
Last updated: Mar 16, 2023